NovaBay Pharmaceuticals Inc (NBY)
0.0751
0.00 (0.00%)
USD |
NYAM |
Apr 23, 12:38
NovaBay Pharmaceuticals Profit Margin (Quarterly): -110.2% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -110.2% |
| September 30, 2023 | -53.81% |
| June 30, 2023 | -44.16% |
| March 31, 2023 | -55.67% |
| December 31, 2022 | -225.3% |
| September 30, 2022 | -3.55% |
| June 30, 2022 | -58.85% |
| March 31, 2022 | -3.39% |
| December 31, 2021 | -4.98% |
| September 30, 2021 | -101.1% |
| June 30, 2021 | -87.15% |
| March 31, 2021 | -84.01% |
| December 31, 2020 | -92.90% |
| September 30, 2020 | -148.4% |
| June 30, 2020 | -112.5% |
| March 31, 2020 | -83.62% |
| December 31, 2019 | -157.6% |
| September 30, 2019 | -17.46% |
| June 30, 2019 | -139.8% |
| March 31, 2019 | -281.0% |
| December 31, 2018 | -34.98% |
| September 30, 2018 | -48.95% |
| June 30, 2018 | -56.87% |
| March 31, 2018 | -72.96% |
| December 31, 2017 | 12.56% |
| Date | Value |
|---|---|
| September 30, 2017 | -59.81% |
| June 30, 2017 | -42.16% |
| March 31, 2017 | -108.4% |
| December 31, 2016 | -40.42% |
| September 30, 2016 | -108.7% |
| June 30, 2016 | -101.0% |
| March 31, 2016 | -295.3% |
| December 31, 2015 | -257.1% |
| September 30, 2015 | -436.8% |
| June 30, 2015 | -484.8% |
| March 31, 2015 | -862.5% |
| December 31, 2014 | -910.0% |
| September 30, 2014 | -2.78K% |
| June 30, 2014 | -2.39K% |
| March 31, 2014 | -1.24K% |
| December 31, 2013 | -811.2% |
| September 30, 2013 | -350.1% |
| June 30, 2013 | -477.4% |
| March 31, 2013 | -393.0% |
| December 31, 2012 | -211.1% |
| September 30, 2012 | 2.20% |
| June 30, 2012 | -255.6% |
| March 31, 2012 | -191.7% |
| December 31, 2011 | -295.0% |
| September 30, 2011 | 3.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-225.3%
Minimum
Dec 2022
-3.39%
Maximum
Mar 2022
-83.39%
Average
-84.01%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Eyenovia Inc | -307.7K% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -125.7% |
| Return on Assets | -69.74% |
| Return on Invested Capital | -114.9% |
| Gross Profit Margin (Quarterly) | 48.70% |
| Operating Margin (Quarterly) | -21.41% |
| Return on Net Operating Assets | -105.0% |